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Famllf Hannliig w eontr&oeptlon Is 9M aaoltnt 
ai history* Different typt» of herbs» pXmt e^raots 
and neahanleal means w e emplo^ red hf varlotts oM l l s a * 
tlons and sooletles to prevent pregnane/ in anoient 
times. In modern times, at least until 1960» various 
types of spermatooidal agents, meehanioal barriers or 
the Rhythm methods vere relied on to control or prevent 
conoeption, mat none of these proved oompletely effeotive* 
I t vas in 1960 that Hnous ushered in a new era of oral 
eontraception with the introAmotion of the *pill* that 
brought about virtually 100^ effeotiveness in oontrolling 
oonoeption* In 1968, i t vas estimated by Qaroia and 
David (1963) that 14 million vomen %rere using oral oontra«-
oeptives for f e r t i l i t y control in the vorld. 
Although these drugs have h i ^ rate of effective* 
ness yet they have a number of side-effeots. These 
include headachey nauseay vomiting^spotting, metabolic 
alterations, thromboembolism etc, Xn order to increase 
the acceptability of these drugs, i t is necessary that 
these side-effects are removed altogether| or reduced 
to their minimum, for this purpose a knowledge of the 
precise mode of action of these contraceptive drugs is 
necessary, Xt has been suggested that these drugs may 
be acting by inhibition of ovulation (Pincus 1968>, How-
ever, other sites of their action at the ovary, fallopian 
t 3 t 
tube^ mtemsi o«rvlea3. naotiB , np^m tr«nf]>ort| 
tlon^l^ve betn propose A (C)»ng, X967b)« fh^re wte many 
gftpt in 007 kaovledg9 in tltit iira»« 
Til® objsotlve of tbd F«s«aroh work p^ea«nt«d in 
this dissertation was to ftud^r « eertaia atpoot of the 
mod« of action of oontraoeptivo drugs at tlia iiterino 
level* M s relates to the interaction of oont^aoeptiv* 
steroids vith estrogens* In pertieiaiirt tho affeot of 
nosethynodrel on the uptake of radioaotiire estradiol in 
the nouse uterus has been studied* 
t S I 
a i l i n n SlI ^ I I & I A I I & E 
The oontraeeptive steroids have a common baste 
steroid nueleusi the eyclopentanoperhydropheiutiithrene ( I ) 
The nuabering system used to desigimte various carbon 
atons In the steroid naoleus i s given in Figure !• 
1 
CD 
There are three types of important naturally 




EstrogensI The estrogens have an aromatic A«ring ( i . e . a 
ring %rith 3 double bonds) and a hydroxyl group at carbon 3 
of the nucleus. They lack an angular metl^l group at 
carbon ( i . e . carbon Id and associated hydrogen atoms)• 
The estrogenic components used in the contraceptive 
preparations are 1) Ethynyl estradiol (XII). 2) Mestrsnol ( IV) . 
t 4 t 
fh«3r deriT«d from estradiol (IX> and ooatftitt in 
ethynyl group (-G^OH) in 17a posltioAi ii^^h Imparts 
tilglt oral aotlvitsr to them* Batradlol la poorly affaetiir* 
aa an eatrogan idian admlnlatarad oralljr* Maatranol alao 
eontains a aotlql group at oarbon 3 henoe knovn ai 
othywyl «»tradlol-r3»'aethyl ether CEB3l!e)* 
Clll) ( I V D 
C-C=CH 
. mi, ^ teatoaterona (7) and 
progaaterona (VI) are ^ oxoaterolda. Thay hacva 
a double bond between oarbon of tlie mtoleua and m 
ketone ( >0«0> at oarbon 3» Both haira angolar methyl 
group at oarbon 10 and oarbon*13» Teatoaterona (V) beara 
a hydroxj^ group at o i 7 position) vhlle progesterone (VI) 
bears an aoetyl group at the 017 position. 
C v i ) 
s 5 I 
Il^t S ^ W W ^^^ coatrae^tiv® 
preparations are eategoriased Into groups $ 
Xd-nor taatoeteroae derivative* (VII)• 
S« 17a-ao0toxr progasterone derlvatlvai (VIIJ) 
evil) CVlllO 
Ilf^ a If-aftir oompounds 
are derivod from 19-nor tastosteronaC?!!)« 
tastostarona diffara from taatoaterona <iV) in that 
Old angular mathyl group attaohad at C*10 is midsing* 
ThBf a l l hava an etlijrnyl group <»OsCB> in the 17a 
position of th® steroid aolaotula. I t Is apparently tMs 
group vith 19«>nor struotura that imparts hi|^ oral 
activity to thasa compounds, 
fhB axamples of this group arat 




t « I 
g) HoJPethlnarono acdtate (IX) I t nopethleateron® 
vith an aoetate group at C-17» 
C1X3 
3> HoretliyiiodFeX (X) * I t dlf fe?* fi»oii Horetbitteron* 
in posseiting a double bond in 5 (10) position 
instead of tlia 4-5 position. 
OH-, 
CX) 
f 7 I 
4) BthynodioX dlaeetmto <XI) - I t I t t i » most pot«at 
progftttmgen avmllable* 1% bears an euctetate group 
at G^ B and C-17, 
r -C^CH 
9) IiSmeatreaol <3CXX} ^ Xt is a 3»deox7 X9-aor ooMpound 
( ! • « • ketone group at 0*3 is missing). 
CXIO 
these oonpounds are 
derived trom iTa-hydroxrprogesteroae aoetate (XIII>» Iher 
are slnilar in struetore and possess either a xethyl group 
or n ohlorine at 06« Some oontain a double bond between 
und C^also. This substitution at earbon 6 enhanoes their 
oral potenoi'* Three eompounds belonginc to this group aret 
I 8 I 
c x i i i ) 
3.) Me^oxar progesterone aoet&te (XXT) * Xt bears a 
metliyi group (Cfi^) at 0-6 itt alpha poiltlon. 
^-0-li-CH-: 
C X I V ) 
2} NegestPol aoetate CX7) * I t bears « netbga group at 
0-6 position and a double bond between 0»6 and 0-7« 
t 9 t 
3) Chloraadliione acetate (OT) • I t 1>ear» a ebloriiie 
atom at 0*6 poiitlon and a douUe toond betwen 
0-6 and (S-7# 
c y v i ) 
fhfi various oral oontraoaptlve preparations majr be 
used as I ) combination tberap^i progestationaX steroid 
is given in oombination vitb an estrogen S) sequential 
therapyi estrogen is given from day 5 to i5 or 00 and 
progestagen from day 16 or SO to 3) Low dosage oonti* 
nuenii administration of progestogen* Besides tbesei tliere 
are other methods of administration of oontraoeptive 
steroids l ike 4) long term injeotable preparation 
5) long aoting pi l ls 6) Implants 7) post ooital contra-
eeptives* The amount of estrogen and progestin used in 
any of the oontraoeptive preparations varies* Modes of 
administration under C4)*(6> are s t i l l in olinical tr ia l 
stage. 
In oombination and sequential therapyi the estrogen 
administered may vary from SO ug to 160 ug, vhile progestins 
I 10 t 
from 1 mg to S mg. Haeentl^ tbift Conlop O^otmittee 
Appointed by tilt British Ootropnmeiit, has reoonaenM 
that not mre thsii SO ug of meatvaml or 9thfayX 
•itmdioX used in th» ooMbination therapy* 3hii 
reooamendation hmi baen iddoly aooojjtdd* 
Low dos9 oontiimoos aaainistratlon of progettiiis 
involT«<s tho adoiziistratlon of progestagon Xikt 
ehXormadinone aoetata <0«5 mg) oontiimoualy, Hoipgestral 
(XVXI) in as snail an amount as 50 to 75 ug has btefi 
suooessfolXj tFied as a oontinuous low dosaga progestin* 
Coutinho ft DaSoasa (X968) hava suooassfttXXy used Horges* 
treX <0,5 «g ft ,05 iig Bthyoyl estradioX) as other 
day piXl^ for oontraoaption* fha iStug is talcan on 
aXternata days fron day 5 to di^ 25 of tha nanstmsX 
oyoXa* 
C X V I I ) 
In onoa a month piXX or Xong aoting piXX tharapyf 
a oycXopentana other of othynyX estradioX (qwinestroX m i l ) 
is administered as 6,0 mg tabXat, iidth a progestin of 
short duration* 
I U f 
( X V I I I ) 
Iiong toting Injectable is usuaXljr an ester of 
2.7 ^estradiol sueh a« estradiol valerate (XXX) or estra-
diol enanthate (XX)* the progestagen used idtli or idtbout 
estrogen is 17a-hfdrox3r progesterone oaproate (XXX) and 
medroxy progesterone aoetate CXXV), 
Cj)0CCCH2)3CH3 
Post ooital oontraeeptives are synthetio estroganSt 
they have proved very effeotiva as post ooital oontraoeptlvas 
and interfere vith iaplantation* Doses of Olethylstllbestrol 
(XXXX) from 6 to 60 agiss or mpu of Sthynyl estradiol 
administered 4*5 days after ooitas aay prevent implantation 
in ifoaen« 
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(Ih3 CH3 
C X X l l ) 
Seaidet ttm varioui other iio&«»8teroldal 
drugs involving ^tik estrog«&« or anti-estrogtnt are also 
being invostl gated for ferti i ltsr oontroX* Maiar of tliste 
oompounds s^dvont iapXtntation or ftffeet oorpnt Xutoua 
funotion* 
finottt (X955> f i rs t reported tliat the probahXe node 
of aotion of oontraoeptive drugs is bgr inhibition of 
ovuXation. fhi» was further oonfiraed hy the studies on 
animaXs and vomen. TiXX reeentXy inhibition of ovuXation 
was considered as the prinoipaX mode of action of oontrm* 
ceptiYe drugs. However, due to a careful study of Martinea-
Manautou et aX(X967) i t is raaXized that inhibition of 
ovuXation is not a "conditio sine qua noni'* for anti« 
fert iXity effects of steroids, this ef fect oouXd aXso be 
achieved by the action of contraceptive steroids at other 
sites Xike endoaetriua, faXXopian tubes, cervicaX nucus^ 
ovary eto* which ara direotXy iwroXved in the processas 
of reproduction. 
M 1.3 I 
In spito of exteniiv0 Atudioif vetf l i t U t is Imovn 
Ahmt tho ex&et no4tt of m%im of ooiit?aoeptlir# iteroidt* 
Diaortpanoidt ari i* ppobably due to tllo failure to realizo 
%h&t oloselr related eompoonas mf dlitlnetly 
difforent modes of aotioa at different dose levels and 
that oonpoimds imd tlielr ooffibinatlon aay liave snitii^le 
modes of aotioR« irarlous sites of aotioti of 
oontraoeptlire steroids aa^ be enmerated ts follows f 
1, Pituitary gland and ^pothalttniiS 
2m Ovarian responiiveness 
3. Tubal factors 
4. Cervical factors 
5* indoBetrial factors 
Hormally the pitiiitarsr ^and under tke stiisalation 
of the harpothalaiBas secretes tvo gonadotropic hormones | 
f o l l i c l e stiisalating hormone (fSR^ and luteinizing hormone 
(LH>, FSH stiaolates the ovarian foll icular development 
and function and L I brings about ovulation and formation 
of corpus luteum. Since oral contraceptives inhibit 
synthesis or release of thete gonadotropins 93H and |»I| 
ovulation is inhibited. This is also evidenced by the 
fact that the ovary at lapartttomy •hoirs an absenee of 
fresh corpus luteum in women taking oral contraceptives 
(Qarciai Pincus St Bock 1958, Ostergaard 1964) • the 
ovaries are also reduced in size, acquire a smooth surface x 
and a white Juvenile appearance« fheir histological 
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appearanoe reveals early arrest of foll icular development. 
Besides tlie examination of ovary at laparotom/i 
the ovulation inhibition is indicated by the estimation 
of urinary or plasma FSH and LE levels in women taking 
oral oontraoeptives, !i!he normal urinary LH exeretion 
is estimated by bioassay method (Stevens and ?orys 1967) 
and by radioimmunoassay method (Wide 1966) • Hidgley and 
j a f f e (1966) estimated plasma levels of LH immunologically. 
LR seoretion estimated by bioassay or W radioimmunoassay 
vas oharaeterized by a marked mid oyole peak* This mid 
cycle I»H peak l^as much more marked in plasma than in 
urine probably due to ^ low renal clearance of LB as 
compared to FSH (Kellar 1966)« 
Serum FSH levels rise during menstruation and 
are high early in the proliferative phase, they then 
decline to a preovulatory nadir just before mid cycle 
LH surge (Taymor, ikono, fheteplace 1968, Ross, Cargllle, 
Lipsett, Rayford, Marxwall, Strott, Hodbard 1969) and 
rise again to a second peak roughly coincident vith 
LH peak* This paraovulatory FSH peak is neither as 
dramatic nor as consistent as that seen for LH. 
The ef fect of contraceptive drugs on LH and PSH 
levels has been studied by Mmy workers (Taymor, 1964; 
Kaiser, Wide and Qemzell, 1966) L^rltzen, 1966) Stevens 
and Vorys, 1967| Bell, Herbst, Krishnamurti and Garcia 
1967) Dicsfalusy, Qoebelsman, ;rohan8son, mi inger and 
Vide 1969) Larsson^Oohn, Johansson, Wide and Qemsell 1970). 
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On tht basis of their vork i t i f oonoXttdtd that both 
estrog«ns md progtstagtns interfere vith pttoitaory 
gonadotropin funotion, Qie iomediate ef feot of eatrogeni 
being directed tovards dijdnation of FSB secretion vhile 
that of progestageni towards the abolition or suppression 
of aid 03role LH peak. Both together inhibit the fSH and 
l>H secretion and thas prevent oimlation* 
Estrogen alone in snail doses of 10*SO ug seens 
to atiamlatt fSH secretion (Vorjrs, Ifllery A Stevens 1965) 
but in the doses of 80«>100 ug i t aarkedl|r diainishes 
i t (Vorys et al 1965) and prevents aataration of ovarian 
fo l l i c l es , the conclusion that adeq:uate aaount of 
aestranol ( i » e « 80 ug or nore) inhibits fSB secretion 
is also supported by the f inding obtained on seiiuential 
regiaen (Stevens and Yorys 1967)* Long tera administration 
of estrogens in higher doses depresses the aid cycle 
LH peak (Voryt et al 1968). 
Progestagens given alone generally suppress the 
aid cycle LB peak (Lauritsen 1966| Gauae Ik Kaiser 1967). 
Z.OV dosage continuous adainistration of progestagens such 
as 0»5 ag^daily of chloraadinone acetate (Larsson-Cohn, 
;rohansson,Vide and Qeasell 1970; ISiosfaiusy, Goebelsaan» 
Johanisson, T^linger and Wide 1969), 8.5 ag lynestrend 
CSchaidt«63,aendorffI Kaiser, and Kopera 1967) and 0*1 ag 
norethisterone (Dlcsfalusy et al 1969) etc. do not suppress 
the aid cyde LB peak consistently. Instead suppressed 
or abortive LB peaks aay be foraed which aay or aay not be 
aoooapanied by high pregnanediol excretion in the urine 
I 16 t 
Cm«zf«lus3r ot «X X969)« 'Sm i t Is e^rldtnt; that th* 
oontraoeptlvo offset ot low do«e progestagens My or 
may not ovulation lnlilbltlon« fhay aay iiavo othar 
sites ot aietlon« 
Qmm fi^ppysj^vmsf^;, 
!Kiat contraceptive steroias «ay Inhibit ovarian 
response to gonadotroplo stlinaatlon is suggested W 
animal experiments (Stamp St Ostergaard 1966$ Hears 1965) 
Blozfalttsy 196S. Revlavs) and also tyy reports that tha 
administration of progesterone (Qemsell at al 1960) or 
oontraoeptiva steroid eomblnatlon (Gunl 19671 Itaiirltsen 
1966) suppresses ovarian reaetlon of vomen to exogenous 
gonadotropins. Other Investigators using different 
eompounds and dosage sohames oould not demonstrate sueli 
an ef feot of eontraoeptive steroids on the ovary* Indeed| 
in two oases, eiEOgenous gonadotropins ware shorn to induoe 
ovulation in 16 out of 18 treatment oyoles on oomfeinatlon 
eontraceptives (Starup and Ostergaard 1966| J^ohannisaon, 
Tilllngar and Slosfaltisy 1965)* Ibveveri in these tvo 
oases, the gonadotropin atiiBnlation« was i&dauhtedly 
excessive* therefore, the possibility oarniot be disregarded 
that certain eontraoeptive steroids diminish the ovarian 
sensitivity to gonadotropio stlmalationi but that this 
e f feot oan be overcome by the addition of Inoreased amount 
of gonadotropins. Besides these, there are certain oontra* 
captive steroids l ike dihydroiqrprogesterone aoetophenide 
(XXXZZ) which completely inhibits ovarian response to large 
doses of pregnant mare's serum (IMS) in prepuberal monkeys 
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CK«r and Ohandrm 1965) i^Xe otiiert l ike prG$ii««-4, 16-
dlona*3| aD^iilone CmV) aarkedir lii07e&««8 til* ••nsltlvit^ 
of th® yhsittt «oiik»y ©vn^y to pregnwit «are»i «enui. 
So i t «pp«aift ttiat lAportaat diffftr^noet aa^ axlat iMtwdeii 
varioua ty|ie« of ateroldi with regard to thdlr direct 
af feot on tli« ovary. 
( X X I I I ) ^XIV) 
OontraoaptlVQ steroids Aajr aiao Interfere ^ t h tlia 
biogenesis (Ostergaard a Stamp 1968) and/or metabollsn 
(OoldMan 1967> of progesterone in the ovary* This has 
been suggested on t^ ie basis of reports that In i««aen 
on eontlnaous lov dosage progestagen» fresh eorpora lutea 
and Seoretorjr endo«etrln» have been found aceonpanled 
bjr lov pregnanedlol levels (Martlnes-Manautou, Olnger* 
Velasques, Cortes-gallegos, ilsnar, Rojas, Qoltteres-
Najar and Radel 1967b)« She saae vas reported by 
ostergaard and Starup (1966) in a study of 7 vosen on 
ethsmyl estradiol and megestrol aoetatei separately 
or in sequential therapy. 
t %B I 
EAQMS 
spermatozoa underoertain ph^miologioal ohange 
termed Capaoltatio&i in tlie femala ganital traot before 
they oapable of fertlXisiiig tlie egg. In most mas>ma3.t| 
•permatosoa liave to be oapaoltated, in the female genital 
tract* tTttoapaeitated speratatosoa are unable to penetrate 
through the sona pelltiolda of the •$g$ (Austin 1967) • 
This prooesa whloh wmy take pXaee In the uterine or tubal 
oaratiei haa the fo le of enabling the apermatoaoa to 
undergo an aorosose reaetlont iMoh in turn oauaes release 
of hFftluronidase and f ^ antjme nakea i t possible for the 
spermatosoon to pass through the oumulus (Austin 1967)* 
this aechanitm seems to be operative in htman speeies 
too (Sdvards, Donahue, Baramki and Jones 1966)* 
fhat oontraoeptive steroids may possibly interfere 
with the proeess of oapaoitatlon is based upon the 
observation that administration of progesterone to 
rabbits' inhibits the oapaoitatlon of spermatozoa in the 
female genital traot (Chang 1958). Further studies 
by Chang (1967a> have shovn that |)vetreatment of rabbits 
with progestational steroids oauses a disturbanoe in 
the sperm transport and sperm oapaoitatlon. 
^bal transport of ova may be one of the processes 
influenced by the oontraoeptive steroids. In rats 
(nnous 196&> and rabbits (Chang and Bar par 1966) i t 
is established that administration of estrogens a day 
or tvo after insemination indaoes degeneration of biasto-
oysts due to the rapid transport from the tube to the 
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uterus itnd tximXalon from uteruf. Ctunu (1967b) liat 
roport«a that treatrntnt of rabbits with progtatatlonsX 
ooapoundi prodaoss « aarksd « f f eo t on tlis transportctlon 
of oggs, oausinf soo* disturbatioo in fsrtiliBatioiiy 
ddgoneratlou of oggs in tlio uterus tikd tlioir oxpiatioA 
from tlie uterus* !Eho motilit^^ of huttan falXopiaa tube is 
]mom to be infXueaeed in yitro bjr pituitary adrenal 
and ovarian hormones (Borie Hewton 1966$ Sandberft 
Ingelman^Sundberg, tlndgren and Hyden 1960). HOveferi 
^ ^ i s ^ t r o effeot of oontraoeptive steroids on tb.a 
tubal aiotUity In t^e huaan is not yet Icnoum* 
fUe denudation of oira of their corona radiate^ 
cells is one of tho important prooesses which takos lO^ aoa 
in the fallopian tube and without whioh fert i l isat ion 
cannot take plaoe* Xn vitro denudation Of ova oould 
not be achieved on the addition of hyaluronidase or spem 
suspension alone, bat i t vas possible after the ova were 
treated with sperm suspension in the presence of pieoes 
of tabal mtioosa in the medium (Susuki dt Hastroianni 1966)* 
TSm e f fect of eontraoeptive steroids on the tubal auoosai 
the absence of whi<di affected denudation of ova needs 
to be explored farther« 
Suinmarislng one could say that tubal factors are 
oertainly of importance in ensuring fert i l izat ion and 
proper transport of ovum. Bstrogens and progestins are 
capable of interfering vith these factors in several 
species* Whether they do so in the human is not known* 
t m I 
CervleaX imottt under goe$ oyolie ehsngoi, dovllig 
normal menst^ roal oyoXo indueed lif dstrogent ia ^ 
foillottiar | l^iat« and fegr progdsterone la the XutesX phase* 
Before or at the tine of ovia&tloii the oervioaX Haout 
le exeesslveljr thin and vateryt Xt ia oharaiteriaed W 
Xov viaeoaitr, m dminished ooneentratlon of aXhmnini m 
aarkedXjr increased oonoentration of non^adgratiiig anieold, 
as veXX as W i ts ahlXitgr to show fern Xike arborisation 
and inoreased spinnbarkeit (Moghissi X966a and Xd66b, 
Moghissi and Nei^us X966). these changes are in favour 
of sperai penetration throu^ eervioaX inaoas <BoteXX»* 
|.Xusia X964> and are estro^n induced. Curing the XuteaX 
phase, the oervioal stuoos is thiolc, tuokjr and eeXXnXar, 
Xt shows poor spinnbarkeit and Xaek of fern Xihe arborisation, 
the ratio of aXbiimin to mooid is naoh higher than in the 
nidcyoXe isaous. 9uoh ohanges in the oervicaX nnoas are 
hostlXe to sperm penetration (BoteXXa->LXti8i* X9$4) and 
are induced bif progesterone* Shase progesterone and 
estrogen-indnced changes in the oerTieaX ouoiis can be 
dupXicated bgr the adninistration of estrogens or proges-
tagens (Moghissi X9$6a). fhe adninistration of oembined 
contraceptives resnXt in progesterone*conditioned ohsngeS 
in the oervicaX sRtoas. These ohanges are considered 
significant for the contraceptive effects (Zanartn X964) 
as they definiteXr inhibit spera aigration throa|^ 
cerilcaX mens (Ifoghissi X966a OdebXad X966>» 
I I 
S«<|iienti«l oontiftQeptlv^ therapy liat no e f f « o t on 
th« oarvleal aueiis pirlor to tlui adnlnistratlon of {xrog««** 
tagtns (Cohen and 1965)• tharaforo, h l ^ 
eontraoeptlT* affioae^ of thl i fe^laan Mist b« Involirlng 
otiier points of attaok (Quali Baoerrai Rlot*i&a3r| 
Ooldslaher 1967, and S^er 1966)« 
Slid adslnlatratlon of lov dotago prottstogant 
reiults in non^aupprassion of anioaatrlal ohangos acoompaniad 
hT oiiangaa in tba vlaootitjr and apinnbarkait of oerrieaX 
muooa. Since low do«aga progestogans are affeotlira oontra* 
eeptlTas thair ant l fer tUi t f «eehaniam liaa iMan anggastad 
to iavolva an Inhibltorr affaot on oarvloaX an&etia (Cobon 
9k Pa?as*peXaas 1965) • But raeant stadlaa of Mar tinea* 
Miinauton and lils aasoolataa (1967b) on tha affaot of 
0J5 ng ebloraadiaona acetate on Siaa«Bii!mer post« coital 
teat of eerrieal aacua shoved that in aOf( of 115 oasesi 
tha sparai Botll lty vas lacking, vhlle in 80^ the nosber 
of speraatosoa was fair to good and exhibited good , 
motility, ISierefore, the f e r t i l i t y protection offered 
by lov dose progestagen could not ba attributed to i ts 
e f fect on ceryical miotts alone, Zt »ay have other loci 
of action too. 
Certain progestins, l ike tha retrosteroid dydi»o-» 
gesterone, vhen adninistared to noraally aenstroating 
voaen result in tha typical progestational changes in 
tha eerrieal ancos* fha aacos la thick at aidoyde idth 
poor longevity of a paras and absence of ferning. Bat tha 
an t i f e r t l l i ^ ef fect of this steroid Is slight i f any 
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(Baekar 1962}. This together with the faet, that endo-
cervleal spexa density eoiapatlblft idth pregnanoT i s i^ ot 
knowni nakes one fee l that although the changes in tha 
oervical Mttcus mgy contribute to the eontr&oeptiv* 
efficacy* more conclusive evidence i s needed before these 
changes can be considered as a principal aeohanisai by 
which progestagens induce tenporary steril ity* 
The huaan endoMtrium exhibits characteristic changes 
in each aenstrual cycle under the sequential stimulation 
of ovarian horaones. In the f i r s t part of the cycle, the 
foll icular phase, the endoaetriua i s under the influence 
of estrogens. There i s then a gradual transition at the 
tiae of ovulation and as the luteal phase progresses, the 
e f fect of progesterone becowes doiiinant* These aorpholo* 
gical effects are associated with intricate blochenical 
changes* Animal experinents indicate that endometrial 
changes, regulated by delicate estrogen progesterone balance, 
are crit ical for ii^lantation in several species (Bishop, 
Borell, Diesfalusy d: TelUnger 1968, Pincus 3965} • 
I t i s vei l known ^a t al l the changes characteristic 
of a proliferative endlonetriuii can be induced by th* 
adadni strati on of estrogen and those seen in the secretory 
endoaetriUB can be duplicated following administration 
of various progestins. In vitro, ef fect of estrogen and 
progestins on endometrium in culture has also been shown 
to be similar to their in vivo ef fect (Csermely, Hughes 
and Demers 1971}. I t can be expected, therefore, that 
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thft hlstoehesiieal pattern of thft endOKetrltn eattolblts 
aignlfieant differenea aecordlng to ttm typ« of hormonal 
eontrao0ptlv« adolQlstored. Indeed the patterns found 
in woiMa taking eoisbined p i l l were markedly different 
froB those found in aet^uential treatment, whereas during 
continuous progestagen adminlstrationi two patterns 
energe - one consistent with ovulation axiA another 
suggesting anovulation. 
Combined the oomMaed estrogen and progestagen 
p i l l i s generally administered from day 5 to day 26 of the 
menstrual eyele* In an ovulatory cycle of women, secretory 
changes begin in the uterus after ovulation and formation 
of functional corpus luteum around day 16 end reaeh a 
peak on day 29-20 to be followed by rapid regression. When 
a w^an is administered, combined contraceptive on day 5 
of the cycle, there i s an early and transitory glandular 
response and secretory changes in the endometrium reach a 
peak within 4-6 days of drug administration. Glandular 
regression then begins to occur. At the conclusion of the 
20 day regimen the endometritai may show coip^lete absence 
of glandular secretion and tortuosi^ to one with some 
cellular and intraltmdnal secretion and minimal to 
moderate tortuosity of the gland. The stage of a fuUy 
develc^ed secretory endometrium i s rarely i f ever reached. 
(Haqueo-fopete, Peree-Vega, Qoldsieher, Martines-Manautou, 
and Rudel 1963, Maqueo*.Topete and Rice-Wray, 1966). A 
thinning of the endometrium takes place after a few cycles, 
but cyclic changes are known to occur even after long term 
administration (Garcia 1967}. However, the menstrual 
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f lov , sub»e<|u«itt to thi disoontiimatlon of treatotnt 
vlth tfaft eottliiJiea p i l l , ia tumiair «8sooUt«d with noii* 
•eeretof7 «trophi0 appearing dtidosetriua (Sorkin, Iiia 
and Kim 19d5>, Zt shovs no dallf Tavlatlon in voXuni| 
and is signifioantiy rddaeed as compared to tliat ieen in 
voffien vith nonaaX e^relei (callardf Litofaky & Be Merre 1966)* 
Sequential p i l l i - fhe aeqiiential p i l l adadnistration 
reattlte in a Berked proliferation of endo&etrii» followed 
W the appearanee of early aeoretory ohangea (!?arl£in et al 
1965)» Shere i i no appearance of eachausted or atrophic 
^andi* fhe endosetrim has the appearanee of el^teenth 
to nineteenth day endometritua of an ovulatory oy^e of a 
normally nenatruatlng Momnn^  and does not loeeose thinner 
on continued adnlnistratlon. the aenstroal f l o v following 
sequential regimen is associated with a ieoretory endo« 
metrium (Curkin et al 1965) and its Oration approximates 
the normal. Vblloving a long term use of sequential 
contraceptive therapy, the post-treatment endometrial 
regeneration is significantly more rapid than in thosa 
tsking combined pi l l* In sequential regimen where estrogen 
is given for 11 dsys and estrogen and progestagen for 
10 days I the appearance of endometrium at various phases 
of treatment approaches that of normal (Hears 1965), 
Continaoas proiesteien admlnistretloqt> misn contra* 
caption is based on continuous progestagen administration 
the histologic appearance of the endometrium shows much 
greater variation than in other types of hormonal contra* 
ceptives, Xt ranges from inactive to seeretory vith a 
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f a i r araount 0f irregalar secretory typt {Mariinfts-Maaautou 
nt wX 1966 and Xd67b>« I t is of aliziiflcanea that 
seeretory eiidomatrim la found laora fra^ently evon after 
long term itsa of tlia progestins (Hartlns^-tfanantou at al 
1967b) • 
lifflfi, m^^K I** a<3ziiliastratlon of 
long aotlng Injeotable praparationi result. In a s l l i^ t 
to eactraiae glandalar Involution and andosetrial atrojj^ 
espeoially in eases inhere tha Injeotabla doas not eontain 
a long aoting estrogen oomponent. ^en tha af feet of a 
eoshination of estradiol enanthate and 6s7«dihydro3Ey 
progesterone aoatophenlde was studiedt approximately one-
third of tha biopsies shoved secretory aotiirity iihereas 
tifo-thirds exhibited no eiridanoe of glandular sa^etlon* 
The importanoe of endometrial changes introduoad 
by oontraoeptive drugs nay not be over«emphasised| but i t 
is erident that any Imbalanoeof estrogen and progesterone 
ratio, other than in normal oyda affects implantation 
in many speoies (Pincas 196S, Bnder 1963). Hlastooyats 
in many rodents wil l imiaant in almost any tissue <Kirby 
1967) but the endometrium certainly represents a most 
important exception in this respect < Uncus 1965| Bnders 
1963)* the anti-imiaantation action of a drug l ike 
clomiphene in the rat Is on the internal milieu of tha 
endometrium rather than tha blastocyst* Although much 
is not knovn about tha human, yet i t msy be possildka 
that estrogen and progesterone given in tha esrly proli-
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feratiir« ph&s* mtCT able to ctemte m *>horaonaI 
iabalanot** interfevlng vith sonsud dnd^Bfttrisl deveio]»* 
ment ana mplentatlon (Badal 9t Ha:irtln«8»ll&nautou 1967) • 
JeiUQn and J'aoobfon (1962) h&ve nade the ploneerlnf 
stTudltt on t!a uptako of estradiol In Uia rat utarui* 
After a sln^e suboutaneous injection of 0*1 ug of 
6»7-^B-estradlol of blgh spaoiflc a e t l v l ^ (50 a/nH) 
tha homone Is Incorporated and retained iJi tlie rat uteruf 
and vaglnaf in contrast to tba other tissues like Hirer, 
kidneyi adrenaS^ssisdei bone and blood. She peak of 
estradiol upteka in the uterus is reached betveen 1 to S 
hours and thereafter a gradual deoline orer the suooeediag 
hours vas obtained v l ' ^ a algnlfleant drop at 16 hisurs. 
Tha amount of estradiol present in the uterus is onl^ r a 
small fraction never exceeding 0»1 to O.S % of the 
adninistered dose. TTp to six hours aftor the administration 
of phr^ioXogioal amounts of trit iated estradiol the only 
significant radioactive substance present in the uterus 
is free estradiol. Fortheraore idien a nlxture of 6,7-% 
estradiol and estrone 17-% vere employed, i t was seen 
that neither the immature nor the aotively growing uterus 
is capable of oxidising estradiol to estrone* On the 
other hand two hours after the administration of tritiated 
estrone, the uterus contains tritiated estradiol vbich 
is 1/10 of the content resulting from the sane dose 
of estradiol i tse l f * this stron^y suggests that 
estradiol stimulates uterine growth without undergoing 
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iBQtmboXlo trazisformatiozi m^ that ostrons m r t * i t » 
hoBionaX aotlon in t!i« utema, after iiaixii oonirarted 
into estradiol* 
Stadias of Sweat, Bpyson and totmg (1967) have 
ahown that in honab both endometriim and njMte^iini 
in the proXiferatlTe phase are able to transform 
estradiol«17B into estrone* fhe eapaoitf of endoaetriim 
la 40 tiJies that of sorosetrivpa* f t e reverse reaotlon 
i «e « estrone to estradiol ia of less magnitade than that 
of th« forward reaotion. Krishnani Slngorani and 
Lauaai (1971) have reported that hiiBiui endoaetriuia and 
tfyoaetrina in both the proliferative and seeretor^' phases 
of the oy^e are able to oosvert estradiol to estrone* 
Suoh a transformation is found to ba less in the seeretorjr 
o 
phase than in the p^l ferat lve phase* 
Stone and Martin (1964) studied t&e uptake of B^*. 
estradiol and estrone in the utems of ovarieetoaized 
•ouse after local application* Both estradiol and 
estrone reaohed peak oonoentratlon in the utarus approscljub* 
teljr one adnute after applleation followed bgr steady 
deeline over next 18 hours* Xhe rate of deordase in 
activity va« wore rapid vith estrone than with estradiol, 
and Kar explain lover biologloal aotivitgr of estrone in 
looal tests* 
Jensen and oovorkers (1968) have shoim that etlQmjrl 
estradiol and mestranol administered in tha ssxa amounts 
as trit iated estradiol are taken up by uterine tissues in 
a maimer similar to that found vith estradiol. 3oCyolo* 
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pentane ether of this compound (QulnestroX) has been 
shown to be stored unaltered In the brain. 
aub>cellular dlstrlbntlon of estradiol 
Centrifugal fractionation experlaients demonstrated 
tvo sites of estrogen binding In the uterine oells. 
Stumpf (1968) using autoradiography teolmlque has shovn 
that in the rat tissues most of the estradiol (60*68)0 
resides In the nucleus, both In the endometrium and 
mjrometrltim but a certain amount Is bound to a macromole-
cular substance appearing In the supernatant fraction* 
Further Jensen et al (1968) have suggested that 
the Interaction of estradiol with t a r^ t tissues InvolTes 
a tvo«step mechanism of uptake and retention. Ttie 
hormone associates tpontaneously with an extra nuclear 
"Uptake receptor" to form 9.5 3 complex, ®iis 9,5 S 
complex transfers estradiol to the nucleus by a temperature 
dependant process which consumes 9*5 S receptor. The 
formation of 5 3 complex by the nucleus requires the pre-
sence of supernatant fraction containing estradiol In 
the form of 9.5 S complex. I t Is suggested that 9.5 S 
complex may be transformed into the nuolear 5 S complex 
by cleavage of the 9.5 S receptor molecule. 
Korethynodrel uptake 
tJptake studies with norethynodrel (I.atuaias, Halkanl 
A Laumas 1971) have shown that after an Intravenous 
Injection of %»norethynodrel, I t Is rapidly taken up In 
the genital neural and other tissues of rat. The rapid 
upt«k« i t fol lov«d f i r s t W arapid aiaappearfmety and 
thtn hy iiow ditmppctranoe* In this respeot noretl^gmo^eX 
shows simixaritias to profesteipo&e vhioh aXso has hoea 
fotma to be rapidly takan up bar thasa tissues and than 
disappaa^i rapidly (XiauAas 9t faroo«i 1966), I t differs 
from estradiol vhleh is incorporated and retained in 
the uterus, vacina and pituitary* tt i s possible that 
Borethynodrel Mgr trigger a biologioal erent and aet 
without retention in oontrast to estradiol vhieh aots 
through retention. Horethynodrel again shOM an init ia l 
rapid disappearanee folloved bjf a slov disappearanea 
in tha plasna of vo»en (Lauaas, Murugesan and 
Slngorani, 1971)• 
9ie uptake of progestational steroids ziorethinodrona, 
norethynodral and ethomodlol diaoatata vera studied by 
Watanabe et al (1968). Ihey showed that there is no 
seleotiTa uptake and retention of these steroids bgr the 
tissues of tha rat* Ihe Tarlous tissues studied included 
ovary, uterus» vagina, pituitary, hypothalaims adrenslf 
l iTer, kidney eto* 
authoradlographic taohni(|uas, dtunpf (1968) 
showed that norethynodrel is not looallaed in tha nuclaus 
of tha calls of innatura rat uterus« in contrast to that 
68jt of estradiol is ooncentrated in tSie imolaus. 
OBIBOfZVB OF tm FRB3BKT BWU 
Estradiol is known to be incorporated and retained 
in the uterus as described earlier (lensen Jacobson 1962)« 
X nwber of steroid structures including estradiol, 
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oo»pit« vitH tH* uptak« of radioftotiv* «8tra41oI in tlii 
tttevus, thus retultl&c in m itUdbitioB ot uptaka of 
% aitradlol in tht utemt (Korennan 1969) • HoveTar, 
previous vork from thii laboratory had i&dieatad tliat at 
a oertain dos« levaXf estradiol I tsal f may itimilata tho 
uptaka of radloaetiva aitradiol in the ut&m»» Krtmy 
and tarry (1970) Kada a syiteiaatio investigation of th9 
effaot of pretraatmant of aatradlol on tlia uptaka of 
aatradlol in tha BOttia uterui« It mui thovn that an 
optimal dota laval of 0*03 ug of aatradlol par 
innatore noiisa vaa auffiolant to atiaolata tha uptaka 
of ®»»oatradlol. 
Xt vai of interaat to inrastlfata tha affeot of 
progestational ateroidt on tha uptaka of radloaotiva 
estradiol in tha uterus, fhis would help in an under* 
standing of the action of oral progestin-4 in the endo-
metrium and provide information as to hov these progestins 
modify the aotion of endogenous estradiol in tha uterus, 
I^evious nork in this oonneetlon has shovn that norethyno* 
drel a progestational steroid inhibited tha uptaka of 
estradiol in the rat uterus (Sisenfeld and Axalrod, 1966)« 
Xn viev of tha faot iAmt norethsmodrel possesses some 
estrogenic activity i t vas considered of interest to 
systeoatleally investigate ^a affeot of norethynodrel 
on the uptaka of estradiol in the uterus. |n order to 
achieve this obiectlva, the e f fect of pretreatment with various 
doses of norethynodrel at different times on tha uptake of 
estradiol in tha mouse uterus has bean studied. 
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mTMA^s Ai^ p mmm 
AnlmaXli « Xnmftture f«mal« i»ic« 22^23 old of th* 
A«I,X,M*3, ooXony werd Ii9«a in this sImSjr. 13m saimals 
v«r « housed in alr*oo&ditio&«d quArter«« Kothers of tht 
pups vMpe atintained on th* pel l « t diet ^imfaotai^ed ligr 
tho Bindttstan Leveii^  Ltd. | Bonbay. 
C . t A E9tra4to3rf Jhe trltiated ostradioX speelfleally 
Xali»0Ued in 6|7 position (Sp, 4lot 44 Ci/ndt) ol»tain«d 
from tlM Veir BngXand ^ifporation Bostoni Haiiff 
I t vas purifiod ooXuion ohromatography* 
odXite ooXnnn vaf ttsad with a aobiXa phase, heptanet 
toXuene (4s6) and atationarr pbaae methanoXivater 4iX. 
Fraotions nmaberins 102 of 8*0 uX each were eoXXeeted. 
A XO^aXiquot of the Tariouf fraotloni was added to the 
sointlXXatlon Tiias and oounted tow radioaotivit/ in a 
Faekard Liquid SointilXation counter* A gpuph wai pXottad 
ahovn in Fig.X* l^aotion* No* 38*66 m e pooXed and 
the purity of the radioactive eetradioX thue obtained 
vaa further tested bgr paper chroitatography in a Bush 
sfstem with nobiXe phase, petroleum etherttoXuene (2tX) 
and stationery phase, aethanoXtvater t4tX>, About X uo 
of ^H-estradloX was spotted on the paper, along with 
radlo/onert estradloX* the paper was run in the above 
system for nearXy three hours t U l the soXvent front 
had reached about X inch from the bottom of the paper, 
fhe paper was taken out* 9ie strip oontalnii^g radio* 
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aotlvtt atttradloX •oaimed on « i^arottatogram teamiei^  
Mod«X Ho.7200* A linifLa iharp peak of radioaotlirlty 
Qorresponding to radlolnert estradiol vaa obtained 
<Fig.2). lltla oonfiraed the radio oheaioal piiritf and 
homogenity of the purified 6|7-^H-ettraaiol» 
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HadioaoJiroBiitograo nam of jniplfled 
6,7,3B-ilstr»dlol» 
t 3a t 
dstra^lol w ad^nlstered subcfutoneousxy In 0*1 lol/ 
p&t inimalf injeotion folutton propartd in 
#tliftttolio saliiid* 
e g , A n Injactlon 
•olution of padioinapt estradiol was prepared in 50 
ethsnoXio i«liiiO| 0.1 iia of tbi$ solution eontsining 
•01 ug of estradiol was injeoted per noase* Hadio* 
inert estradiol vat obtained froa 0tgmL ohemieal oompaaif* 
loretbynodrel inaeetioni Horeth^modrel lo t 
free of estrogenic ooatamination %ras a g i f t from l%r. 
Victor A, Brill of Searle ft (Moagof U^S.A. 
tlie injeetion solution %ras prepared in B^ ethanolio 
Saline, l^ lilui iiigiier doses of noretl^odrel vere adadnis* 
tered| the proportion of ethanol vas inoreased to 
aohieve solubiliaation of noretbynodrel* 0#1 lal of the 
injeotion solution tms suboutaneously injeoted into eaoh 
mouse* 
•Iroeedur^* Pretreatsient vith radioinert noretliynotoel 
or estradiol vas i^ven to tlie animals for different periods 
of t i « e and dosage as described in the results # !lowefirert 
the uptake of 6,7-% estradiol vas always studied bf 
injecting i t one hour before the aniasls were kil led. 
Five to 10 immature female tnloe 22*33 day old were used 
per group* At saorifioe the uteri were (|ui<^7 reiaoredi 
dissected free of e>ctraneoiis tissue and weighed on a 
torsion balance after unifora blotting to renove excass 
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f l t i ia. The uteri vei'® tr«nff#rrea directly to eounting 
vials and dissolved in 0*3 aX Hyanliw hydroxld* (Paekard 
XAstrument Co*}. I f neoossary th« sainplas were l e f t In 
an incttbator at 56% overnight* After the tissues were 
thoroughly dissolved, 15,0 ml of dlotol was abided to each 
saDtple, Radioactivity vat determined by liquid scintillation 
speetroaetery* Quenching corrections were nade wil^ the 
help of an Internal standard. The results are expressed 
as disintegrations per minute per mg wet weight of the uterus* 
ppunting Procedure! Counting of the radioactivity was 
carried out in a Packard Model No.3214 liquid scintillation 
counter* The scintillation liquid was made i;^  of PPO (2|5-
Biphenyloxazole) 4 gns, Diaethyl POPOP (1,4-bls- 2.(4.Methyl-
6*-phenQrloxazolyl) •Benzene) 0*1 gn dissolved in 1 l i t r e of 
redistil led toluene. The dlotol scintill&tion liquid was 
made up by dissolving 78 gas., nepthalene, 4«85 gois PPO and 
0.19 gms POPOP in 226.0 ml methanol, 375.0 ml. of disti l led 
Dloxane and 375.0 ml of disti l led toluene. 
The counting efficiency of the machine for trltSmm 
was about 33jf. 
Bta^lsU^dl tfteXYili 
The mean of the estradiol uptake In the control 
grotqp of animals expressed as DPN/mg uterus was taken as 
100* The uptake In the treated group was expressed as % 
of the control value* The standard error of the mean of 
treated group was calculated end compared with the corres-
ponding value of the control groi;|) using Student " t " test* 
The data analysed statistically Is given In Table X* 
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Sf f «at of Q>01 lig of noyettemodrel and ogtr&dlol pgt* 
Die re:it2lt8 of thas« exp«7ittents ure pr@s«ated 
in Fig,3. I t a«7 be seen theit 0»01 mg of estx*adlol pre* 
treatBwnt to laaatuv^ liloa prodao«d 4 statlstiosaxsr 
•IgniflQint Inoreas* X) In til* uptaka of 
eatradioXf vlian pratrentnant vai glvan tor 8|4 or 6 
hours. Whan pretreataant vith tlia aa»e doaa of aatradloX 
ima giiran for alght tmrn^ I t did not prodnoa anjr affeot 
on tha iiptaka of ^H^astradioX In tha utemi* 
tha data on tha affaot of pratraataant vlth 
O.OX ttg ot norethynodral on tha itptalca of ^B*astradloX 
la aXto ahovn In Fig, 3* Pratraataant vlth norethynodraX 
for or 8 hoars did not prodaoa asgr algnlfieant 
Inoraasa or daoraasa (fabla Z) In tha uptaka of 
astradloX* Bovarari a pratraataant of 4 hours produoad 
a algnifloant Inoreasa In ^a uptaka of %*astradloX» 
tha pattern of uptaka of %-aatradloX after pretraatmant 
vlth 0,0X ug of astradloX and norethsmodraX shov siol* 
Xarltlas in that the BtaxlnaX stlamXatlon la attained 
whan pratraataant Is given for 4 hours* 
ffl<ydyeX on th^ 9f M ffWf 
She effeot of pretreataent idth O.X, X.O and itO ug 
of norethynodreX for 4,8 and X8 hours on the uptaka of 
t 39 t 
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O—Q Oooixtg ESTRADIOL PRETREATMENT. 
•A A O-O lA*- g- NORETHYNODREL PRETREATMENT. 
lOO 
TIME C HOURS ) 
Flf.3. of ®H.B«tradlol In the nouit uterui 
» f t « r iipetrefttatnt with 0,01 ug Bstrndiol 
•r 0.01 uf »or«thynodP«l for 8,4,0, liiid 
8 liourt. 
t 40 t 
eitradlol is gkvn in Flg»4. ftpetreatment for 4 hmr* 
I 
n t h any of tlie alsovt doses of norettiynodrtX resulted 
In » statistically si^i l f ioaat inoroase la the tiptaka 
of ^H»estradiol in the uterus, jpretreatmeut for 8 and 
X8 hours idth the above doses of norethsmodrel resulted 
• Aitmfmmmm in tlin apt^e Of ^Ekestradlolt Qompared 
with the uptake of 4 hoars pretreatnent* the tritlated 
estrflidiol uptake at 8 and 18 hours after pre treatment 
vith 0«1 and 5,0 ug of norothynodrel is almost in the 
range of the eontrol« however, the pretreatment with 
1,0 ug of norethsmodrel for 8 and 18 hours s t i l l showed 
a stimt^ation of uptake of H»estradiol whieh vat 
signifioantly higher than the control lerel* 
the pattern of stinolation of 0.1| 1.0 and 5,0 ug 
of norettoQpnodrel was similar to that presented for the 
pretreat«ent with 0,01 ug estradiol and 0«01 ug 
norethynodrel. Bie only noteworthy differenoe is that 
the pretreatment itlth 1.0 ug aorethgmodrel had a lasting 
stimulatory ef feot on ^es t rad i o l uptake and this eould 
be observed even upto 18 hours. 
Ihe data for the e f fect of 4 hours pretreatment 
with different doses of norethynodrel on the uptake of 
^fikestradlol is given in Fig,5. I t shows that the »a<imal 
stloulatlon of ^K-estradlol uptake was obtained with 
1.0 ug norethynodrel. Doses lower than 1,0 ug or higher 
than 1,0 ug produced lesser stivulatlon in the uptake of 
I 41 I 
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M8 NORETHYNODREL 
Stlfflolation of ^H-Bstradiol uptak* after 
p;;Seata«at with 0.1 i^t, 1-0 J^ O ug, 
10.0 tig inA 50»0 ttg norethynodPtl fo* 
4 boturti 
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•stradlol. ]¥dtreatment vith XO ug norethyiio<!r«X did 
not thov ineroat* 07 d«craaa« of ^S*dstradloX uptaka* 
Hiowaver, SO u« of norettaynodrel prodaead a statlfltiealXy 
t i l ^ f l e a n t <TabXa I ) deoraasa In tha uptaka of 
astvadloX oompared vith tlia eontroX. 
t 44 t 
since J«ii««n ibA lacotofon (ld«8> deiaonatrated 
that rat mterai oan aemanulata and retain aatrddioX» 
a muBbep of ia^astl gators liava oontrilmted to the 
Qonoapt that tha uteraa ooataina eatrogen reoeptots. 
the uptalce of ^B»estradioX In ^ uterus has been 
foimd to ba oompatitlvali^ inhibited lijr estradiol and 
a zmaber of estrogenio and antiastroganio oompounds 
(Korenaan 1368)« Sstradlol in higher doses of 10 tig 
has been shoum to inhibit the uptake of ^-estradiol 
in the uterus of nousa and rat Ctarenius 1965| 
Korenaan 1968>* toreth^modral has been shorn to 
inhibit the uptaka of %-estradlol in th^ same aanner 
(BisenfaXd and Axalrod 1965). 
A oareful studsr of tha af feet of pretreatmant 
of mice idth norethjmodrel has shovn that i t oan prodaoa 
a stinulatonr or an inhibitory e f f ec t on tha uptake of 
g 
H^estradlol in tha uterus and this depends upon the 
dosage of norethynodrel used and tha tiaa of pretreatmant* 
Norethynodrel pretreatment in tha doses of 0*01, 0*1, 
1.0 end 5«0 ug for a period of 4 hours produced stinala*-
tion in tha uptake of %-estradlol. lha maxlmiA stinnalat* 
ing af feot vas exerted by a dose of 1*0 ug of norethjmo** 
drel at 4 hours. Prolongation of tha tisie of pretreat* 
nent with norethynodrel for 8 or 18 hours resulted in 
tha waning of this af fect for s l l other doses except 
tha 1*0 ug dose« ^ s dose eontinued to produce a 
t 50 t 
•tlamlatorjr affeot on upt^« of %-®stradlol ^ Oim 
pretreatffiont was ^ven for 8 and 18 Hours* a»v9Ter, 
the axtaat of ®B»efltradiol uptake vaf lowar at 8 lOiA 
18 hours as oompared vlth uptake seen at 4 hours. 
A dosa of d0»0 ug of noratbynodral produead m Inhibi-* 
tlon of taia uptake of ®H-a»tradlol la the siouse uterus^ 
fhe results preseuted in this dissertation show 
for the f i r s t time that a progestational steroid l ike 
norethynodralI not only inhibits the uptake of 
estradiol and aots as i ts oompetitive inhibitorf but 
also stioulates i ts uptake* Sauoier« Banerjeei 
Brazeau and Bosain {1970) in a recent study shoved 
that administration of 100 ug norethynodrel per 100 pi 
body veigiht to rats 16 ainutes before and 15 ninutes 
3 
after the administration of !l*estradlol produced a 
reduetion in the uptake of ^B»@stradlol* fhese authors 
concluded that norethynodrel produces a oompetiti'Te 
inhibition of the uptake of estradiol. 
Eisenfeld and Ascelrod (1965) using a high dose 
of norethynodrel SSO ug/100 m hody vAi|^t) reported 
that norathjmodrel aots as a competitive inhibitor 
of estradiol uptake ^ o h has been confirmed by Saucier 
et al (1970). The present results are in agreement 
with the above studies, iihen a relatively hii^ dose 
of norothynodrel (60 ug) is used for the pre treatment* 
She findings of stimulation of ^B»estradiol uptake by 
relatively small doses of norethynodrel have a slaUaril?^ 
to some of the earlier reports (Laumas 1967i Laumas and 
t 51 t 
Farooq unpubXtshdd olnervaUonii Blsenf«Id and 
166; Kri»3r St Baiaek 1970> in i«iildli ftoall dotes of •stra* 
t 
diol vdre to ataxMB a stlwalation in tha u^aka ot 
^B-ettradlol. Kraffr and Blaak (1970) Made a dataiXai 
stttdjr of the ef feet of estroean isrimlng on tha uptake 
of %»e«tradlol W tlia aoiiae mtesiis* I t waa taen tliat 
0*03 ug estradiol pretreatment for 3*6 lumrs produced 
a maxiiaaX stiisalation of ^B»estradlol uptake* 
%n the present l^e st l » i lat lon of 
estradiol uptake vith norethynodrel prialng he due 
to two poasitailltiea. Firstly, i t may he to tase 
inherent estrogenic activity of norethynodrel* Horethyno^ 
drel has he en reported to possess 7% of the estrogenifi 
potency of estrone(lrill,1966j Edgreni Jones and 
Peterson, 1967). the seoond possibility may he due to 
the estrogenio metabolites of noreth^fnodrel vh t^ say 
he exerting a mild estros^nio e f feot on the uterus as 
also noted vith very small doses of estradiol* Arait 
Golabi Lajme ^ Pinoos <1962) isolated 17^ ethynyl-19-
norandrost-4-ene»3p, lOp, 17p.triol as one of the major 
urinary metabolites of nore^iynodrel, which has heen 
found to possess estrogenic activity (Bialyi tayne 4 
Pinous, 1965)* I t is possible that the mild estrogenic 
activity of this metabolite of noretliynodrel stiaulatei 
the uptake of "fikestradlol in the uterus. Yadava and 
Laumas (1969) studied the metabolism of tJ-'C^^  glucose 
in the rabbit uterus after prolonged administration of 
t 47 t 
norethjmodrel and found «n inov«ated rate of i inthei l i 
of l ip id , WK and protoin. Xhii otosei^atlon tvupthfiT 
eontlTW the estrog^nio propertlet of noretli^modrel 
and i t « tt6ta1>oXitei, iinee estifogant are Icnovn to 
inoreas* l ipid| WSk and protein aynthesia in the utsrut 
(tJl & llaeUer 1963). 
t 48 t 
H FI IL LI S A I IH I 
She reitats obtained in tlie present investigation 
shoved tliat priming vlth 0*01 ug of estradiol for 4 hours 
proceed uptake of ^B«estradiol vhen tlse uptake in 
the control uterus was taken as 100^. k siniilar nagaitude 
of uptake of %>e3tradioI vas observed vith the prising 
of I»0 ug of noretharnodreX for the ftase period of time. 
I t thus beeomes obvious that a priming dose of norethyno* 
drel whloh is 100 tiaaa more than that of estradiol 
produces an ef fect similar to estradiol pretreatnent* 
A dose of norethynodrel whioh is SO times i ts stimilatory 
dose of 1«0 ttg» produoes an inhil^itorsr e f fect on the 
uptake of estradiol* A progressive rise in the uptake of 
^fi^estradlol was seen vith a priming dose of 0*01| 0«1 and 
1.0 ug of norethjmodrel for 4 hours. A priming dose of 
1.0 ug of norethynodrel for 4 hours produced the maxioum 
stimulation of the i^ptake of ^ es t rad i o l and after thl i 
there vas a decline of upteike with doses of S ug end 
10.0 ug of norethynodrel. At s t i l l higher level of 50 ug 
i t produced an inhibition of the uptake of ^B-estradiol* 
these observations lead to the ooncliasion that norethynodrel 
produces dose dependent changes vhioh may affect the 
action of endogenous hormones in the uterus, this n«3r 
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